Bristol-Myers Squibb Profitability Analysis

BMY -  USA Stock  

USD 68.15  0.58  0.84%

For Bristol-Myers Squibb profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bristol-Myers Squibb to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bristol-Myers Squibb utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bristol-Myers Squibb's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bristol-Myers Squibb over time as well as its relative position and ranking within its peers. Continue to Trending Equities.

Search Current Profitability Trends 

Price to Sales Ratio is likely to rise to 4.24 in 2021, despite the fact that Return on Sales is likely to grow to (0.16) . Net Income to Non Controlling Interests is likely to rise to about 20.5 M in 2021, whereas Accumulated Other Comprehensive Income is likely to drop (2 B) in 2021.

Bristol-Myers Squibb Revenues

34.94 BillionShare
The market value of Bristol-Myers Squibb is measured differently than its book value, which is the value of Bristol-Myers that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol-Myers Squibb's value that differs from its market value or its book value, called intrinsic value, which is Bristol-Myers Squibb's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol-Myers Squibb's market value can be influenced by many factors that don't directly affect Bristol-Myers Squibb underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol-Myers Squibb's value and its price as these two are different measures arrived at by different means. Investors typically determine Bristol-Myers Squibb value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol-Myers Squibb's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bristol-Myers Squibb Current Valuation vs. Price to Sales Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Bristol-Myers Squibb's current stock value. Our valuation model uses many indicators to compare Bristol-Myers Squibb value to that of its competitors to determine the firm's financial worth.
Bristol-Myers Squibb is rated second in price to sales category among related companies. It is the top company in current valuation category among related companies reporting about  51,074,585,635  of Current Valuation per Price to Sales.

Bristol-Myers Current Valuation vs. Price to Sales

Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Bristol-Myers Squibb 
MV Per Share 
Revenue Per Share 
3.62 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Bristol-Myers Squibb 
Enterprise Value 
Market Cap + Debt 
184.89 B
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Bristol-Myers Current Valuation vs Competition

Bristol-Myers Squibb is the top company in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Drug Manufacturers—General industry is currently estimated at about 208.02 Billion. Bristol-Myers Squibb totals roughly 184.89 Billion in current valuation claiming about 89% of equities under Drug Manufacturers—General industry.

Bristol-Myers Squibb Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Bristol-Myers Squibb, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bristol-Myers Squibb will eventually generate negative long term returns. The profitability progress is the general direction of Bristol-Myers Squibb's change in net profit over the period of time. It can combine multiple indicators of Bristol-Myers Squibb, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for 2021
Accumulated Other Comprehensive Income-1.8 B-2 B
Consolidated Income-9 B-9.2 B
Net Income-9 B-9.3 B
Net Income Common Stock-9 B-9.3 B
Net Income to Non Controlling Interests20 M20.5 M
Operating Income-6.9 B-7.1 B
Income Tax Expense2.1 B1.9 B
Net Income Per Employee-297.2 K-305 K
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol-Myers Squibb operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 30250 people.

Bristol-Myers Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Bristol-Myers Squibb. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bristol-Myers Squibb position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bristol-Myers Squibb's important profitability drivers and their relationship over time.

Bristol-Myers Squibb Profitability Trends

Bristol-Myers Squibb profitability trend refers to the progression of profit or loss within a business. An upward trend means that Bristol-Myers Squibb's profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is Bristol-Myers Squibb's gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.

Bristol-Myers Squibb Profitability Drivers Correlations

One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between Bristol-Myers Squibb different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards Bristol-Myers Squibb in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down Bristol-Myers Squibb's future profitability.

Use Bristol-Myers Squibb in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bristol-Myers Squibb position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol-Myers Squibb will appreciate offsetting losses from the drop in the long position's value.

Bristol-Myers Squibb Pair Trading

Bristol-Myers Squibb Pair Trading Analysis

Correlation analysis and pair trading evaluation for Bristol-Myers Squibb and Horizon Therapeutics. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Use Investing Themes to Complement your Bristol-Myers Squibb position

In addition to having Bristol-Myers Squibb in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Tech Funds Thematic Idea Now

Tech Funds
Tech Funds Theme
Funds or Etfs that invest in companies involved in research, development, testing, or distribution of technologically based goods and services. Tech Funds theme has 40 constituents.
View All  Next Launch Tech Funds
Continue to Trending Equities. Note that the Bristol-Myers Squibb information on this page should be used as a complementary analysis to other Bristol-Myers Squibb's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Screener module to find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Bristol-Myers Stock analysis

When running Bristol-Myers Squibb price analysis, check to measure Bristol-Myers Squibb's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol-Myers Squibb is operating at the current time. Most of Bristol-Myers Squibb's value examination focuses on studying past and present price action to predict the probability of Bristol-Myers Squibb's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bristol-Myers Squibb's price. Additionally, you may evaluate how the addition of Bristol-Myers Squibb to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
To fully project Bristol-Myers Squibb's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bristol-Myers Squibb at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bristol-Myers Squibb's income statement, its balance sheet, and the statement of cash flows.
Potential Bristol-Myers Squibb investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Bristol-Myers Squibb investors may work on each financial statement separately, they are all related. The changes in Bristol-Myers Squibb's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bristol-Myers Squibb's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.